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Surgical TechniquesHybrid coronary artery bypass grafting and transaortic
transcatheter aortic valve implantationEsther M. A. Wiegerinck, MD, Riccardo Cocchieri, MD, Jan Baan, Jr, MD, PhD, and
Bas A. J. M. de Mol, MD, PhD, Amsterdam, The NetherlandsEvolving less-invasive surgical techniques potentially
minimize surgical trauma and reduce the risk of cardiac
valve surgery. Transcatheter aortic valve implantation
(TAVI) has emerged as an alternative for patients facing
high or even prohibitive risk with conventional aortic
valve replacement (AVR). Concomitant coronary artery
disease (CAD) is a well-known comorbidity in degenera-
tive aortic valve stenosis and has been identified as an
independent factor for increased mortality in patients
undergoing AVR.1 The presence of CAD in patients
undergoing TAVI is estimated to be as great as 75.6%.2
Simultaneous percutaneous coronary intervention (PCI)
has been reported although TAVI is currently considered
a stand-alone procedure. Significant coexisting CAD re-
quires preprocedural PCI.
In patients with significant complex CAD, rendering
them ineligible for PCI, revascularization ideally consists
of coronary artery bypass grafting (CABG). According
to the current guidelines, patients undergoing CABG
with at least moderate aortic stenosis should undergo con-
comitant AVR. Combining CABG and AVR increases pro-
cedural duration and is considered to increase operative
mortality.3
High-risk patients with significant CAD who are ineligi-
ble for PCI could undergo surgical revascularization in a hy-
brid procedure with TAVI, reducing the duration of aortic
crossclamping and cardiopulmonary bypass or even elimi-
nating them entirely, thus decreasing surgical risk. Limited
data are available regarding combined TAVI and surgical
revascularization.4,5
We report TAVI through a transaortic approach during
surgical revascularization in 5 high-risk patients with severe
symptomatic aortic valve stenosis and significant CAD
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First Patient
In the past 3 years, 3 high-risk patients were treated with
hybrid direct-vision TAVI and on-pump CABG.
The first was an 84-year old man with progressive dysp-
nea (New York Heart Association class III) as a result of
severe symptomatic aortic valve stenosis and multiple
comorbidities (including previous CABG) was referred
for AVR. Routine preoperative coronary angiography re-
vealed 2-vessel disease and an occluded venous graft. Oper-
ative mortality risk of a combined CABG and AVR
reoperation was considered high (logistic EuroSCORE,
39.2%; Society of Thoracic Surgeons [STS] score, 11.7%).Second Patient
An80-year-oldmanwith heart failure related to a severely
calcified aortic valve stenosis was referred for AVR. Coro-
nary angiography revealed bivascular CAD with a proximal
left anterior descending coronary artery occlusion and a sig-
nificant stenosis of the obtuse marginal branch of the cir-
cumflex coronary artery. Multiple comorbidities resulted
in an operative mortality risk of 31.2% according to the
logistic EuroSCORE and an STS score of 11.1%.Third Patient
A 79-year-old woman with multiple comorbidities and 3
previous PCIs was admitted for an acute myocardial infarc-
tion. Echocardiography showed diminished left ventricular
function, with apical and septal akinesia and a severely ste-
notic aortic valve. Coronary angiography revealed stenosis
of the main stem trifurcation. She was accepted for a high-
risk emergency combined CABG and AVR (STS score,
32.4%; EuroSCORE, 65.3%).Procedure for First 3 Patients
After median sternotomy, cardiopulmonary bypass was
established by aortic and atrial 2-stage cannulation. Graft-
ing was performed on the beating heart to shorten cross-
clamp time.
In the second patient, the proximal anastomosis was
constructed with the Heartstring Proximal Seal System
(Maquet Cardiovascular LLC, Wayne, NJ).
After surgical revascularization and antegrade blood
cardioplegia, the ascending aorta was transversely incised.
After excision of the aortic cusps, a transcatheter Edwardsery c February 2013
TABLE 1. Summary of cases
Case
Age
(y) Sex
Preoperative data Scores Procedural data
Postprocedural
echocardiography
Presenting
symptom
Peak TG
(mmHg)
AVA
(cm2) EF SYNTAX STS EuroSCORE Procedure
Crossclamp
(min)
Peak TG
(mmHg) AR EF
1 84 M Dyspnea 55 0.9 37% 34 11.1 33.5 CABG, direct-vision TAVI,
native valve excision
35 7 None 45%
2 80 M Heart
failure
42 0.85 38% 28 11.7 39.2 CABG, direct-vision TAVI,
native valve excision
26 19 Trivial 48%
3 79 F Acute MI 40 0.9 26% 45 32.4 65 On-pump CABG,
direct-vision TAVI,
native valve excision
55 11 Trivial 24%
4 80 F Angina 77 55% 43 11.1 33.5 Off-pump CABG, TAVI None 9 None 55%
5 78 M Porcelain
aorta
44 1.2 52% 48 2.58 13.71 Off-pump CABG, TAVI None Mild 45%
TG, Transaortic gradient; AVA, aortic valve area; EF, ejection fraction; STS, Society of Thoracic Surgeons; AR: aortic regurgitation; CABG, coronary artery bypass grafting;
TAVI, transcatheter aortic valve implantation; MI, myocardial infarction; euroSCORE, European System for Cardiac Operative Risk Evaluation.
Surgical TechniquesSapien aortic bioprosthesis (Edwards Lifesciences, Irvine,
Calif) was implanted under direct visualization by intra-
prosthetic balloon inflation. Coronary ostia were patent
after implantation. Aortic crossclamp times were 35, 26,
and 55 minutes, respectively. The aorta was closed with
a running suture, and the circulation was restarted. All pa-
tients were weaned from cardiopulmonary bypass without
difficulty.Postoperative Courses of First 3 Patients
Postoperative transthoracic echocardiography revealed
no intravalvular or paravalvular aortic regurgitation in the
first patient. At 6 postoperative months, the AVA was 2.6
cm2, peak and mean gradients were 19 and 10 mm Hg.
Trivial paravalvular regurgitation was noted postopera-
tively on transthoracic echocardiography of the second
and third patients. Left ventricular functions were similar
to the preoperative situation. All patients initially recovered
uneventfully. The first 2 patients were discharged on post-
operative days 17 and 14. The third patient unfortunately
died of aspiration pneumonia with deterioration of her over-
all clinical status 3 weeks after the procedure.Fourth Patient
An 80-year-old woman with multiple comorbidities and
a recent cerebrovascular accident was referred for TAVI.
She had undergone a previous PCI of the right coronary ar-
tery. Preoperative workup revealed a severely diseased left
anterior descending coronary artery. Extensive tortuosity
of the vessel prohibited PCI. An off-pump hybrid CABG
with TAVI was scheduled. The patient’s STS score was
11.1%; her EuroSCORE was 33.5%.
After median sternotomy, an off-pump left internal tho-
racic artery–left anterior descending coronary artery graft
was constructed. Temporary epicardial pacemaker wires
were placed. Two Prolene (Ethicon, Inc, Somerville, NJ)The Journal of Thoracic and Ca2-0 purse-string sutures with polytetrafluoroethylene
pledgets were placed on the ascending aorta. Balloon dila-
tation of the native aortic valve was followed by transcath-
eter implantation of an Edwards Sapien bioprosthesis
(26 mm) under rapid pacing and fluoroscopic guidance.
Echocardiography and angiography confirmed that the
valve was functioning optimally.
Postoperative transthoracic echocardiography revealed
no paravalvular regurgitation and a maximum pressure gra-
dient of 9 mm Hg. The patient recovered uneventfully and
was discharged 14 days after the procedure.Fifth Patient
A 78-year-old man with progressive angina as a result of
diffuse CAD was referred for CABG. Echocardiographic
workup revealed moderate aortic valve stenosis and regur-
gitation. The patient was accepted for a combined CABG
and AVR by our heart team. His STS score was 2.58%;
his EuroSCORE was 13.71%.
Perioperatively, a porcelain aorta was found. Off-pump
revascularization was successful, grafting the left internal
thoracic artery to the left anterior descending coronary ar-
tery and grafting the diagonal obtuse marginal with saphe-
nous vein graft, with the Heartstring used for the proximal
anastomosis. Subsequent, 2 pledgeted purse-string sutures
were taken onto an area without calcification on the ascend-
ing aorta, allowing direct sheath insertion in a straight line
for device deployment. A transcatheter 26-mm Edwards
Sapien valve was implanted under fluoroscopic guidance.
After implantation, balloon postdilatation was performed
to reduce paravalvular leakage.
Postprocedural echocardiography revealed good valvular
functionwithmild paravalvular leakage.At day6, the patient
was discharged from the intensive care unit; however, his
hospital stay was extended because of development of com-
partment syndrome, and he was discharged 30 days later.rdiovascular Surgery c Volume 145, Number 2 601
Surgical TechniquesDISCUSSION
Combined AVR with CABG and TAVI with PCI are cur-
rent treatment options for aortic valve stenosis with con-
comitant CAD. Currently, treatment strategies are guided
by operator preference and very limited data. At our institu-
tion, PCI is performed before TAVI in eligible patients with
CAD, followed by symptom reevaluation. It is evident how-
ever, that combined AVR with CABG and TAVI with PCI
are less than ideal options for high-risk patients with com-
plex multivessel CAD.
The success of the first hybrid surgical revascularization
and TAVI with reduction of crossclamp and bypass times 3
years ago encouraged us to apply this technique in ex-
tremely high-risk patients. Optimizing the procedure re-
sulted in an off-pump complete surgical revascularization
with an aortic no touch technique combined with transaortic
TAVI without aortic crossclamping and cardiopulmonary
bypass in the most recent 2 cases. This procedure poten-
tially provides an alternative treatment option for patients
with prohibitively complex anatomy for a combined
CABG and AVR.
Excision of calcified leaflets, as described in the first 3
cases, could potentially reduce paravalvular leakage and ex-
pand the indication for TAVI to aortic regurgitation without
valvular calcification.From the Departments of Anesthesiologya and Cardiothoracic Surgery,b the David
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The described hybrid procedure, combining transaortic
TAVI and off-pump CABG with the aortic no touch tech-
nique, shows promising outcomes and potentially provides
an alternative to combined high-risk AVR and surgical re-
vascularization. To our knowledge, this is the first success-
ful implantation of a balloon-expandable transcatheter
valve with native valve excision, potentially reducing para-
valvular leakage and possibly expanding the indication for
TAVI to aortic regurgitation without valvular calcification.References
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for robotically assisted coronary sinus atrial septal defect repairLinda Lau, MD,a Kimberly Howard-Quijano, MD,a Richard Shemin, MD,b and AmanMahajan, MD, PhD,a
Los Angeles, CalifAtrial septal defect (ASD) accounts for 10% of congenital
heart disease and 20% to 40% of cases presenting in adult-
hood.1 There are 4 categories: ostium secundum, ostium
primum, sinus venosus, and coronary sinus defects. Coro-
nary sinus defects, caused by incomplete formation of theatrioventricular folds, are the least common and are often
associated with other congenital anomalies, including per-
sistent left-sided superior vena cava (LSVC; Figure 1).2 De-
finitive treatment of a large coronary sinus defect is
typically performed as an open surgical repair. We report
the case of a patient with a coronary sinus defect in whom
intraoperative transesophageal echocardiography (TEE)
was instrumental in guiding robotically assisted surgical
repair.CLINICAL SUMMARY
A 40-year-old woman was seen with new-onset palpita-
tions and shortness of breath. Preoperative transthoracic
echocardiography and TEE demonstrated a 1.3-cm primum
ASD with a left-to-right shunt, dilated right ventricle, and
pulmonary hypertension. Because of the defect’s location,ery c February 2013
